Myocardial performance in clinical septic shock: effects of isoproterenol and glucose potassium insulin.
D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002302:Cardiac Output; D002404:Catheterization; D004359:Drug Therapy, Combination; D004756:Enterobacteriaceae Infections / Q000150:complications; D004927:Escherichia coli Infections / Q000150:complications; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007545:Isoproterenol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D011188:Potassium / Q000627:therapeutic use*; D011512:Proteus Infections / Q000150:complications; D011651:Pulmonary Artery; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D013268:Stimulation, Chemical; D014655:Vascular Resistance
D007328:Insulin; D005947:Glucose; D007545:Isoproterenol; D011188:Potassium